Study of Accuracy of Triple Assessment as A Clinical Tool for the Diagnosis of A Palpable Breast Lump
Authors/Creators
- 1. Assistant Professor, Upgraded Department of Surgery, Darbhanga Medical College and Hospital, Laheriasarai, Bihar
- 2. Associate Professor and Head of Department, Upgraded Department of Surgery, Darbhanga Medical College and Hospital, Laheriasarai, Bihar
Description
Background: The prevalence of breast-related diseases is highest in both this country and the rest of the world. Breasts may be affected by a variety of lesions, including inflammation and cancer. Some lesions are more prevalent in young females than older women. In cases of non-neoplastic illnesses, early presentation and rapid diagnosis are crucial to reducing worry; in cases of carcinoma, they can prevent metastasis. In this study, the effectiveness of the Triple Assessment as a clinical tool for the identification of a palpable breast lump (physical examination, mammography, and fine needle aspiration cytology) was assessed. Methods: This prospective study was conducted in January 2022 to December 2022 in indoor and outdoor patients at the Upgraded Department of Surgery, DMCH, Laheriasarai, Bihar. Each patient was thoroughly examined, including the pertinent clinical history, physical exam, mammogram, histological results, and management. The study included a total of 50 breast cancer patients who had undergone various treatments. Results: An inflammatory condition was found in 20.0% of the study’s total 10 cases, fibrocystic lesion in 36%, fibroadenoma in 24%, gynecomastia in 2%, and cancer in 12%. In 50 women ranging in age from 18 to 60, this comparative study revealed data from clinical evaluations, mammography, and histological findings. 10% of cases of malignant carcinoma are discovered, compared to 90% of cases of benign breast disease and other conditions. Conclusion: The most prevalent lesion in this study was fibrocystic disease, with an average age of presentation of 30 years. Malignancy was discovered in people older than 47. In contrast to 10 malignant lumps, 90 patients with breast lumps diagnosed as benign by Triple Assessment correlated with the histological findings. As a result, Triple Assessment’s overall accuracy in our study is 100%.
Abstract (English)
Background: The prevalence of breast-related diseases is highest in both this country and the rest of the world. Breasts may be affected by a variety of lesions, including inflammation and cancer. Some lesions are more prevalent in young females than older women. In cases of non-neoplastic illnesses, early presentation and rapid diagnosis are crucial to reducing worry; in cases of carcinoma, they can prevent metastasis. In this study, the effectiveness of the Triple Assessment as a clinical tool for the identification of a palpable breast lump (physical examination, mammography, and fine needle aspiration cytology) was assessed. Methods: This prospective study was conducted in January 2022 to December 2022 in indoor and outdoor patients at the Upgraded Department of Surgery, DMCH, Laheriasarai, Bihar. Each patient was thoroughly examined, including the pertinent clinical history, physical exam, mammogram, histological results, and management. The study included a total of 50 breast cancer patients who had undergone various treatments. Results: An inflammatory condition was found in 20.0% of the study’s total 10 cases, fibrocystic lesion in 36%, fibroadenoma in 24%, gynecomastia in 2%, and cancer in 12%. In 50 women ranging in age from 18 to 60, this comparative study revealed data from clinical evaluations, mammography, and histological findings. 10% of cases of malignant carcinoma are discovered, compared to 90% of cases of benign breast disease and other conditions. Conclusion: The most prevalent lesion in this study was fibrocystic disease, with an average age of presentation of 30 years. Malignancy was discovered in people older than 47. In contrast to 10 malignant lumps, 90 patients with breast lumps diagnosed as benign by Triple Assessment correlated with the histological findings. As a result, Triple Assessment’s overall accuracy in our study is 100%.
Files
IJPCR,Vol15,Issue6,Article195.pdf
Files
(354.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:060e71136cd9cfb0764f83405f49989c
|
354.8 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-06-17
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue6,Article195.pdf
- Development Status
- Active
References
- 1. DeSantis C, Siegel R, Jemal A. Breast cancer facts and figures 2013-2014.Am Canc Soc. 2013:1-38. 2. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology. 2002;225:165– 75. 3. Daly C, Puckett Y. Approach New Breast Mass. StatPearls. 2020. 4. Steinberg JL, Trudeau ME, Ryder DE, Fishell E, Chapman JA, McCready DR, et al. Combined fine-needle aspiration, physical examination and mammography in the diagnosis of palpable breast masses: their relation to outcome for women with primary breast cancer. Can J Surg. 1996;39:302–11. 5. Nigam M, Nigam B. Triple assessment of breast-gold standard in mass screening for breast cancer diagnosis. losr-Jdms. 2013;7(3):1-7. 6. Sanders M, Roland L, Sahoo S. Clinical Implications of Subcategorizing BIRADS 4 Breast Lesions ssociated with Microcalcification: A Radiology– Pathology Correlation Study. The Breast Journal. 2010;16(1):28-31 7. Kumar R. A clinicopathologic study of breast lumps in Bhairahwa, Nepal. Asian Pac J Cancer Prev 2010;11(4):855-8. 8. Ghimire B, Khan MI, Bibhusal T, Singh Y, Sayami P. Accuracy of triple test score in the diagnosis of palpable breast lump. JNMA J Nepal Med Assoc. 2008;47(172):189-92. 9. McFarlane ME. Benign breast diseases in an Afro-Caribbean population. East Afr Med J. 2001;78(7):358-9.